1. Contribution of STAT1 to innate and adaptive immunity during type I interferon-mediated lethal virus infection
- Author
-
Phillip K. West, Nicholas J. C. King, Barney Viengkhou, Iain L. Campbell, Markus J. Hofer, So Ri Jung, and Thomas M. Ashhurst
- Subjects
CD4-Positive T-Lymphocytes ,Male ,Chemokine ,Physiology ,Neutrophils ,Adaptive Immunity ,CD8-Positive T-Lymphocytes ,Virus Replication ,Mice ,White Blood Cells ,Animal Cells ,Immune Physiology ,Medicine and Health Sciences ,Lymphocytic choriomeningitis virus ,STAT1 ,Biology (General) ,Mice, Knockout ,0303 health sciences ,Innate Immune System ,biology ,030302 biochemistry & molecular biology ,Animal Models ,Acquired immune system ,Leukocyte extravasation ,STAT1 Transcription Factor ,Experimental Organism Systems ,Virus Diseases ,Interferon Type I ,Cytokines ,Female ,Cellular Types ,Signal Transduction ,Research Article ,QH301-705.5 ,Immune Cells ,Immunology ,chemical and pharmacologic phenomena ,Mouse Models ,Lymphocytic Choriomeningitis ,Lymphocytic choriomeningitis ,Research and Analysis Methods ,Microbiology ,Virus ,03 medical and health sciences ,Immune system ,Model Organisms ,Immunity ,Virology ,Genetics ,medicine ,Animals ,Molecular Biology Techniques ,Molecular Biology ,030304 developmental biology ,Blood Cells ,Biology and Life Sciences ,Cell Biology ,RC581-607 ,Molecular Development ,medicine.disease ,Immunity, Innate ,Acquired Immune System ,Mice, Inbred C57BL ,Immune System ,biology.protein ,Animal Studies ,Parasitology ,Immunologic diseases. Allergy ,Spleen ,Developmental Biology ,Cloning - Abstract
Signal transducers and activators of transcription (STAT) 1 is critical for cellular responses to type I interferons (IFN-Is), with the capacity to determine the outcome of viral infection. We previously showed that while wildtype (WT) mice develop mild disease and survive infection with lymphocytic choriomeningitis virus (LCMV), LCMV infection of STAT1-deficient mice results in a lethal wasting disease that is dependent on IFN-I and CD4+ cells. IFN-Is are considered to act as a bridge between innate and adaptive immunity. Here, we determined the relative contribution of STAT1 on innate and adaptive immunity during LCMV infection. We show that STAT1 deficiency results in a biphasic disease following LCMV infection. The initial, innate immunity-driven phase of disease was characterized by rapid weight loss, thrombocytopenia, systemic cytokine and chemokine responses and leukocyte infiltration of infected organs. In the absence of an adaptive immune response, this first phase of disease largely resolved resulting in survival of the infected host. However, in the presence of adaptive immunity, the disease progressed into a second phase with continued cytokine and chemokine production, persistent leukocyte extravasation into infected tissues and ultimately, host death. Overall, our findings demonstrate the key contribution of STAT1 in modulating innate and adaptive immunity during type I interferon-mediated lethal virus infection., Author summary The mammalian immune system is divided into innate and adaptive immunity. In response to harmful agents, innate immunity acts first, followed by late-acting, specialized, adaptive immunity. Type I interferons (IFN-Is) are important means of communication between innate and adaptive immunity. IFN-Is mediate their effects via a number of signaling molecules, principally including signal transducers and activators of transcription 1 (STAT1). The importance of STAT1 to the immune response is evident from our previous finding that mice deficient in STAT1 develop a lethal, host immunity-mediated disease following infection with the otherwise harmless lymphocytic choriomeningitis virus (LCMV). In the present study, we characterized the role of STAT1 in protecting against harmful host immune responses against LCMV. We report that STAT1 plays a significant role in lessening both the early, inflammatory responses of innate immunity and the sustained, destructive actions of adaptive immunity. These findings exemplify the extent of STAT1’s role as a key immune response modulating factor.
- Published
- 2020